 |
MUMBAI, India, March 2, 2021 /PRNewswire/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) referred to as "Cipla" today announced that its subsidiary, Cipla Gulf FZ LCC ("Cipla Gulf') is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines in Australia and New Zealand.
As part of this strategic...
Forgotten cups of tea and unnecessary kettle re-boils could be adding more than £1.4 million a day to UK business electrici...
Take business beyond the boardroom. Coogee Bay Hotel has launched a limited-time Coastal Conferences offer, giving business...
As the backbone of the country, small business owners often take on more tasks than they should to ensure growth and profit...
Australia’s business use of artificial intelligence has accelerated quickly. The Australian Bureau...
In response to Tasmania’s growing mental health crisis, a new purpose-built, multi-disciplinary me...
Street Side Medics has officially launched its first ACT-based clinic, expanding the charity’s GP-...
“All the world's a stage.” Shakespeare wasn't writing about Cairns when he penned that famous lin...
Street Side Medics has officially launched its first ACT-based clinic, expanding the charity’s GP-...
As the temperatures drop, the appeal of escaping the city for rolling vineyards, long lunches and ...
Every tax season, Australians tend to fall into one of two camps. There are those who are so nervou...